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Summary: Purpose: Benign familial infantile seizures (BFIS)
is a genetically heterogeneous condition characterized by par-
tial seizures, onset age from 3 to 9 months, and favorable out-
come. BFIS loci were identified on chromosomes 19q12-13.1
and 16p12-q12, allelic to infantile convulsions and choreatheto-
sis. The identification of SCN2A mutations in families with only
infantile seizures indicated that BFNIS and BFIS may show over-
lapping clinical features. Infantile seizures also were in a family
with familial hemiplegic migraine and mutations in the ATP1A2
gene. We have examined the heterogeneous genetics of BFIS by
means of linkage analysis.
Methods: Sixteen families were examined. Probands under-
went neurologic examination, at least one EEG recording, and,
when possible, brain CT and MRI. Clinical information about
relatives was collected. Families with SCN2A or ATP1A2 muta-
tions were excluded from the study. Chromosome 16p and 19q
loci were examined by linkage analysis using two models that
differed in penetrance rate. Genetic heterogeneity was evaluated
with both models.
Results: Clinical information was available for 124 members
of affected families. BFIS was diagnosed in 69 subjects. One
patient without BFIS had a single febrile seizure, and another
had rare episodes of paroxysmal dystonia. Evidence of linkage
was obtained only for chromosome 16. Moreover, the high pen-
etrance allowed the identification of genetic heterogeneity.
Conclusions: Our data confirm the relevance of the chromo-
some 16 locus in BFIS and suggest the presence of an additional
locus. This study shows that the genetic model used affects the
outcome of linkage analysis. Key Words: Linkage analysis—
BFIS—Infantile seizures—Paroxysmal choreoathetosis.
Benign familial infantile seizures (BFIS) is a distinct
clinical entity characterized by partial seizures with or
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without secondary generalization, occurring mostly in
clusters, and with an onset age ranging from 3 to 9 months.
Patients typically have normal psychomotor development
at seizure onset and a favorable outcome (1,2).
The condition is genetically heterogeneous. A first lo-
cus was identified on chromosome 19q12-13.1 (3). Cara-
ballo et al. (4,5) mapped a second locus on 16p12-
q12 and suggested allelism to infantile convulsions and
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choreathetosis syndrome. Subsequently, mutations were
identified in the gene encoding the voltage-gated sodium
channel α2 subunit (SCN2A) on chromosome 2q24 in
two families affected by neonatal and infantile seizures
(benign familial neonatal–infantile seizures, BFNISs) (6).
The identification of SCN2A mutations in families with
only infantile seizures indicated that BFNIS and BFIS may
show overlapping clinical features (7,8). Finally, infantile
seizures have also been found in a family with familial
hemiplegic migraine and mutations in the ATP1A2 gene
(9,10). In an attempt to shed light on the genetics of BFISs,
we investigated 16 families by means of linkage analysis.
We also determined whether the genetic model used af-
fects the outcome of the analysis.
PATIENTS AND METHODS
Subjects
Sixteen BFIS families were selected throughout a mul-
ticenter study (Fig. 1) according to following criteria: focal
seizures with onset between 3 and 9 months of life; nor-
mal development before onset; no underlying disorders
or neurologic abnormalities; benign course and good out-
come, in at least three family members; lack of SCN2A
or ATP1A2 mutations. Each proband underwent a neuro-
logic examination, at least one EEG recording, and, when
possible, brain computerized tomography (CT) or mag-
netic resonance imaging (MRI). Information about seizure
type, developmental milestones, and neurologic state of
the patients’ relatives was collected at home, by tele-
phone, or from medical records. Furthermore, probands
were screened for SCN2A and ATP1A2 mutations by de-
naturing high-performance liquid chromatography (DH-
PLC) and sequencing as previously described (7,9). All
investigated subjects signed informed consent to the clin-
ical and genetic investigations. Families 1 to 7 have been
reported elsewhere (11).
Linkage analysis
Linkage analysis was performed for chromosome 16p
and 19q loci by typing microsatellite markers as previ-
ously described (8). For multipoint linkage analysis, we
used two models that differed in the penetrance rate of the
trait (Allegro 1.0 software). In model 1, we assumed an au-
tosomal dominant trait with high penetrance (90%), as re-
ported by Vigevano et al. (1,2). In model 2, asymptomatic
individuals were not considered in the analysis (“affected-
only” analysis), according to the autosomal dominant low-
penetrance model described by Caraballo et al. (5). For
both models, the frequency of the disease allele and the
phenocopy rate were set at 0.001 and 0.01, respectively.
Individuals affected by febrile seizures or other epileptic
phenotypes were assigned “unknown” affected status in
the analysis. Distances between the marker loci used in
the multipoint analysis were deduced from the Genethon
linkage map.
RESULTS
Clinical data
Information was obtained from 124 family members.
Sixty-nine subjects (37 female, 32 male subjects) were
diagnosed as having BFIS. All pedigrees were consis-
tent with autosomal dominant inheritance with high pene-
trance (Fig. 1). Consanguinity was present only in family
2. Neonatal seizures did not occur among the relatives.
Individual II:6 of family 6 experienced a single febrile
seizure at age 14 months of life but did not have BFISs. De-
velopmental milestones and neurologic examination were
normal in all affected members except for patient IV:3
of family 2, who showed slight motor delay. In one sub-
ject (patient IV:2 of pedigree 2), BFISs were accompanied
by rare, brief episodes of dystonia, involving the arm(s)
and/or leg(s) from age 4 years. About half the patients
underwent brain CTs or MRIs, which were classified as
normal. Seizure onset ranged from 3 to 7 months (mean,
5 months 6 days) of life. The attacks occurred mainly in
clusters, with five to 10 episodes per day, when the patient
was awake or asleep.
Few subjects experienced isolated complex partial or
simple partial seizures, sometimes preceding the onset of
the cluster. The main ictal clinical signs were psychomo-
tor arrest, staring, head and eye deviation, and oral au-
tomatisms followed by a secondarily generalized phase
with clonic arm and leg activity. Interictal EEGs were
usually normal. Nine subjects showed, in the initial active
phase, interictal left or right frontal (two cases) or parietal–
occipital (seven cases) sharp-wave and slow-wave com-
plexes, both awake and sleep. An ictal EEG was recorded
in two patients and showed a focal seizure beginning
with a recruiting rhythm in the left (III:1, family 8) or
right (II:5, family 6) occipital region, spreading over the
hemisphere and then involving the entire brain. Most sub-
jects received AEDs, usually carbamazepine (CBZ), val-
proic acid (VPA), phenobarbital (PB), or benzodiazepine
(BZD), and all became seizure free once the therapy was
started. Seizures remitted before age 2 years in all cases,
and no relapse was reported in any patients during the
childhood. Follow-up in the probands ranged from 2 to 11
years (mean, 5 years).
Molecular findings
As shown in Table 1, we found no evidence of link-
age for the chromosome 19q locus when we applied
either the high [maximum lod score (MLOD), −32.69
at D19S414] or the low-penetrance (MLOD, −22.71 at
D19S414) model. Differently, assuming genetic homo-
geneity, linkage was established for the chromosome 16
locus with both models (model 1, MLOD, 3.43; model
2, MLOD, 10.18, at D16S401) (Table 1). We next used
the homogeneity test to evaluate genetic heterogeneity
(Table 2). For both models, the linkage hypotheses (H1
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FIG. 1. Pedigrees and chromosome 16 haplotypes of the benign familial infantile seizure (BFIS) families. Solid symbols indicate subjects
with BFIS; quarter-solid symbols indicate individuals with febrile seizures. +, paroxysmal dystonia.
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TABLE 1. Family-specific and cumulative multipoint lod scores for chromosome 16p and 19p BFIC loci
Multipoint lod at
Family Model D16S401 D16S3131 D16S313 D16S517 D16S415 D19S414 D19S868 D19S416 D19S425
1 1 −2.86 −2.83 −2.82 −0.79 −2.46 −1.77 −1.38 −1.76 −0.95
2 −1.87 −1.84 −1.83 −0.76 −2.33 −1.51 −1.26 −1.50 −0.90
2 1 −2.76 −2.76 −1.76 −2.02 0.39 −0.95 −2.66 −2.65 −2.69
2 0.53 0.53 0.53 −5.16 −2.17 −1.03 −2.12 −2.01 −2.15
3 1 1.21 1.32 1.29 0.82 −2.52 −0.05 −2.50 −2.50 −0.62
2 1.74 1.79 1.76 1.63 −1.24 0.42 −1.44 −1.44 −0.14
4 1 2.34 2.53 1.52 1.54 −1.51 −2.41 −6.00 −6.36 −7.84
2 1.46 1.50 1.48 1.41 −1.61 −1.53 −3.26 −3.45 −4.51
5 1 1.46 1.46 1.45 1.32 −1.55 1.46 1.46 1.44 1.43
2 1.20 1.20 1.20 1.06 −1.78 1.20 1.20 1.18 1.17
6 1 0.71 0.68 0.94 0.87 −3.28 −2.56 −2.56 −2.56 −2.56
2 0.82 0.90 0.77 0.62 −1.80 −1.63 −1.63 −1.63 −1.63
7 1 0.30 0.30 0.30 0.30 0.30 −2.62 −2.62 −1.06 −0.97
2 0.30 0.30 0.30 0.30 0.30 −2.22 −2.22 −1.05 −0.95
8 1 −1.10 −3.22 −3.22 −2.11 −3.22 −3.22 −3.22 −3.22 −1.90
2 −1.07 −2.22 −2.22 −1.88 −2.22 −2.22 −2.22 −2.22 −1.75
9 1 −0.13 −0.61 −0.62 −0.49 −0.53 −3.73 −2.78 −3.63 −3.63
2 0.59 0.60 0.60 0.60 0.58 −2.31 −1.53 −2.31 −2.31
10 1 1.43 1.46 1.45 1.44 1.44 −0.88 −3.19 −3.15 −3.13
2 1.17 1.20 1.19 1.18 1.18 −0.17 −1.86 −1.97 −1.97
11 1 0.60 0.60 0.60 0.58 0.55 −3.10 −3.10 −2.88 −3.10
2 0.60 0.60 0.60 0.58 0.55 −2.10 −2.10 −2.07 −2.10
12 1 0.88 0.90 0.89 0.89 0.89 −1.86 −1.80 −1.80 −1.80
2 0.88 0.90 0.89 0.89 0.89 −1.80 −1.80 −1.80 −1.81
13 1 −0.23 −0.22 −0.04 0.59 −3.26 −5.30 −5.27 −2.98 −3.22
2 1.19 1.20 1.20 1.05 −1.55 −4.32 −4.32 −1.51 −1.51
14 1 −0.14 −0.45 −2.82 −1.60 −2.82 −0.67 −2.10 −2.76 −2.10
2 0.60 0.29 −1.92 −1.40 −1.92 −0.68 −2.10 −2.10 −2.10
15 1 0.84 0.76 0.76 1.13 −2.25 −2.81 −4.07 −4.24 −3.40
2 1.44 1.50 1.50 1.33 −1.25 −3.04 −4.03 −4.03 −3.55
16 1 0.85 0.86 0.86 0.84 0.81 −4.14 −4.14 −4.14 −3.13
2 0.60 0.60 0.60 0.58 0.55 −2.40 −2.40 −2.40 −2.10
Cumulative 1 3.43 0.82 −1.13 3.25 −24.59 −36.83 −47.84 −46.38 −41.85
lODs
2 10.18 9.03 6.63 7.51 −13.83 −25.11 −32.80 −30.44 −28.11
Cumulative 1 7.54 7.34 6.44 6.74 0.73 0.08 0.07 0.06 0.06
(0.72) (0.66) (0.64) (0.69) (0.18) (0.04) (0.03) (0.03) (0.03)
HETLODs (α) 2 10.90 10.70 9.53 8.82 0.64 0.01 0.00 0.00 0.00
(0.89) (0.86) (0.79) (0.82) (0.21) (0.02) (0.00) (0.00) (0.00)
and H2) were significantly more likely than the no-linkage
hypothesis (H0). However, model 2 did not discriminate
between genetic heterogeneity (H1) and genetic homo-
geneity (H2). We therefore computed lOD scores by as-
suming genetic heterogeneity (HET). As expected, no dif-
ferences were found between genetic homogeneity and
heterogeneity (MLOD, 10.18, vs. HETMLOD, 10.90,
with linkage in∼90% of families) for model 2. With model
1, the HETMLOD score reached 7.54 with 70% of linked
families. These data suggest the presence of at least one
other BFIS locus.
DISCUSSION
The aim of this study was to analyze the heterogeneous
genetics of BFIS by studying 16 families and to determine
the effect of two different methods on the results of linkage
analysis.
Linkage analysis and disease status
A critical element in linkage analysis is the attribution
of disease status to individuals that have different signs
and symptoms of a given disease. Most patients of our
series experienced clusters of focal seizures with or with-
out secondary generalization, and seizure-onset age was
between 3 and 7 months of life. All patients responded
to AEDs and had a good outcome. No BFIC patient or
any relative developed other forms of epilepsy later in
life. A single febrile seizure occurred in only one relative.
However, several affected individuals (mostly probands)
are preadolescent, and we cannot exclude that other types
of seizures or neurologic disorders will develop later in
life.
BFNCs and BFNIS show a typical, homogeneous phe-
notype with different onset age and have many clinical
features typical of BFIS (i.e., autosomal dominant trans-
mission, partial seizures usually occurring in clusters, nor-
mal psychomotor development, and good prognosis) (1,2).
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TABLE 2. HOMOG analysis of multipoint data
χ2 p Value
Hypothesis df Model 1 Model 2 Model 1 Model 2
H2 vs. H1 18.959 3.265 1.4 × 10−6 7 × 10−2
H1 vs. H0 1 15.658 46.881 7.7 × 10−6 7.8 × 10−13
H2 vs. H0 2 34.616 50.146 3.0 × 10−8 1.3 × 10−12
H0, no linkage; H1, linkage, homogeneity; H2, linkage, heterogeneity.
However, some pedigrees include individuals affected by
febrile seizures or other seizure types at an atypical onset
age. Molecular analysis showed that such individuals may
or may not carry the mutation (7,12–16).
Symptomatic noncarriers can be modeled in linkage
analysis by attributing the disease status to all subjects with
epilepsy in a given pedigree and increasing the phenocopy
rate. However, this approach is nonspecific because indi-
viduals with typical and those with atypical features may
be equally considered phenocopies in the analysis. Thus
in BFIS, it is probably more appropriate to reduce the
phenocopy rate and to attribute unknown disease status to
individuals that have atypical epileptic features. Accord-
ingly, the affection status of individual II:6 of family 6 was
considered unknown. Thus the occurrence of the disease
allele on chromosome 16 in this individual is still consis-
tent with linkage but is not taken into consideration in lOD
scores calculations.
Familial infantile seizures have been reported in asso-
ciation with hemiplegic migraine (9,10) and paroxysmal
dystonia (4,5,17). In our series, concomitant BFIS and
paroxysmal dystonia occurred in one case. However, our
families were selected for the occurrence of seizures in in-
fants, and the association with other paroxysmal disorders
could be more frequent in other clinical series.
Linkage analysis and penetrance rate
Linkage studies of BFIS have been carried out with ge-
netic models differing in the penetrance rate of the trait:
fully penetrant (3), moderately penetrant (0.7) (18), and
low penetrant (7). In linkage analysis, the highly penetrant
trait is used for mendelian disorders in which a single mu-
tation accounts for the phenotype. Low-penetrant models
are used for polygenic or multifactorial disorders in which
additional genetic or environmental factors play an impor-
tant role. In an attempt to unravel the heterogeneous ge-
netics of BFIS and to determine the effect of penetrance
rate on the results of linkage studies, we calculated lod
scores in our family sample by using two models that
differed in the penetrance rate of the trait. Both models
confirmed linkage to chromosome 16 but not to chromo-
some 19. In contrast, the low-penetrance model failed to
identify genetic heterogeneity. With the low-penetrance
model, unaffected individuals carrying the disease haplo-
type are invariably considered asymptomatic carriers, and
several families may prove to be linked. Asymptomatic
carriers in idiopathic epilepsy are not uncommon. How-
ever, in the closely related syndromes BFNC and BFNIS,
very few asymptomatic individuals are found among the
tens of subjects carrying KCNQ2, KCNQ3, and SCN2A
mutations (6,7,12–16,19–24).
When molecular data are not available, the penetrance
of a genetic trait can be ruled out from the rate of the
affected individuals among obligate carriers. In our family
sample, only two of 42 obligate carriers with a known
phenotype (II:3, family 12; II:2, family 14) did not report
seizures, which indicates that the trait is highly penetrant.
A crucial factor in linkage analysis in the BFIS syn-
drome is attribution of the disease status to elderly in-
dividuals. Clinical manifestations appear during a very
short period of infancy and leave no signs in adulthood.
In adults, diagnosis can be made only from an individ-
ual’s history, and it may be difficult to track the disease
in past generations. To overcome these difficulties and to
avoid affecting the analysis, it would be more appropri-
ate to attribute an unknown phenotypic status to selected
individuals instead of reducing the penetrance rate.
Our data indicate that a conservative highly penetrant
model leads to the same linkage evidence as a low-
penetrant genetic model and that it is more suitable to
detect genetic heterogeneity.
Linkage analysis and critical regions
Various studies suggest that the infantile convulsions
and choreathetosis syndrome, paroxysmal dystonia, and
BFISs are allelic disorders linked to the same locus
(4,17,25). However, the linkage region is not yet well de-
fined, and discordance appears among the data available
(18). The existence of gene clusters (26) or inconsistencies
in genetic maps (5) may account for these discrepancies.
Alternatively, discrepancies may be due to the analysis
of small families (5,17,18). Pooling of relatively small
families can be used to test a candidate locus by linkage
analysis if unlinked families are not selectively excluded
from the analysis. However, linkage at a specific locus is
supported by the entire sample, whereas single families
are not informative if their lod score is 3. For instance, in
our sample, families 1, 2, and 3 had positive lod scores
for chromosome 2 (1.13, 1.12, and 2.31, respectively) (8)
but were negative for SCN2A mutations. Moreover, family
Epilepsia, Vol. 47, No. 6, 2006
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5 is linked to loci 16 and 19 with a lod score of 1.46
(Table 1).
In genetically heterogeneous disorders, critical recom-
binations in low-informative families may lead to the arbi-
trary exclusion of large chromosomal regions from further
cloning studies. In our opinion, linkage studies should re-
port family-specific lod scores at all investigated loci and
should define the critical regions on the basis of key re-
combinations in families showing a significant linkage.
CONCLUSION
Linkage analysis localizes genes by searching for chro-
mosomal segments cosegregating with a disease. How-
ever, this approach is sensitive to the genetic model used in
the analysis. Our study confirms that BFIS are genetically
heterogeneous, with chromosome 16 locus having a ma-
jor role, and suggests the presence of at least an additional
locus. Furthermore, we show that different methodologic
strategies affect linkage findings and propose an approach
to investigate this condition.
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